News | August 08, 2023
Surging demand for Korean pharma in 2023 ahead of CPHI Korea
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
This transformation will enable GE HealthCare to build a strong foundation for business growth
Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Urges Innovators to produce quality products that can be deployed at scale
New facility will strengthen the security of supply for global pharmaceutical and biotech customers and will support the continued development and production of lifesaving clinical and commercial-scale therapeutics for patients worldwide.
With over 150 leading companies, 300+ topline brands and knowledge-led conference sessions, the event is set to make a grand return to the South
Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22
Subscribe To Our Newsletter & Stay Updated
